Gilead to supply India one million doses of ‘black fungus’ medicine

pharmafile | May 27, 2021 | News story | |   

Gilead Sciences are to supply one million doses of Amphotericin-B to India as black fungus (mucormycosis) cases surge.

The drug has been in short supply, and Prime Minister Narendra Modi instructed to get Amphotericin-B from anywhere in the world.

More than 121,000 vials have so far reached India while another 85,000 vials are on their way.

The company is also withdrawing the stocks available in other countries to supply to India.

An Indian government source told news agency ANI: “Gilead Sciences is working on expediting the supply of AmBisome to India through Mylan.

“More than 121,000 vials have so far reached India. Another 85,000 vials are on the way. The company will supply one million doses of AmBisome to India through Mylan.”

“The Prime Minister had instructed officials to get this drug from anywhere it is available in the world. Indian missions across the world have been involved in securing supplies of this drug. It has been achieved with the help of Gilead Sciences in the USA.”

The infection mucormycosis is caused by exposure to mucor mould which is commonly found in soil, plants, manure, and rotting fruits and vegetables.

Doctors say the infection could be triggered by the use of steroids in severely-ill COVID-19 patients.

Union Minister for Chemicals and Fertilisers DV Sadananda Gowda said on Wednesday an additional 29,250 vials of Amphotericin-B drug been allocated to all the states and union territories.

Lilly Subbotin

Related Content

No items found

Latest content